Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellular Immunity in Hepatitis B Vaccine Non-responders
NCT01451801Phase 4Unknown
- Sponsor
- Aarhus University
- Start
- Oct 2011
- Primary completion
- Jul 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), hepatitis A (HAV), sponsored by Aarhus University. Status: unknown.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)hepatitis A (HAV)
Beyond the preview
Go deeper on NCT01451801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01451801.